NBTX
Q3 2026 EPS Estimate
$-0.15
Sep 29, 2026
Revenue Estimate
$27M
FY2028E EPS$1.91
FY2029E EPS$0.96

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
69
Score
3 Buy (75%)1 Hold (25%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
375%
Hold
125%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$30.00
-27.2%
Consensus
$38.00
-7.8%
Bull
$46.00
+11.6%
12-Month Target Range4 analysts
$30.00$38.00$46.00
Current $41.23Consensus
Current Price
$41.23
Above Consensus
$3.23

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+33.68%
EPS
FY2028
Rev+299.04%
EPS
FY2029
Rev-38.93%
EPS-49.68%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$31M$42M$167M$102M$4M
Low$24M$32M$129M$79M$3M
High$42M$57M$226M$138M$5M
EBITDA Avg$-6M$-6M$126M$69M$-46M
Low$-59M$-111M$92M$52M$-72M
High$57M$125M$179M$96M$-29M
EBIT Avg$-7M$-7M$124M$67M$-48M
Low$-60M$-112M$90M$50M$-74M
High$56M$124M$177M$94M$-31M
Net Income Avg$-16M$-16M$91M$46M$-57M
Low$-69M$-121M$64M$32M$-83M
High$37M$91M$133M$67M$-40M
EPS Avg$-0.34$-0.33$1.91$0.96$-1.19
Low$-1.45$-2.54$1.34$0.67$-1.73
High$0.78$1.90$2.78$1.40$-0.83
Analysts (Rev / EPS)3 / 23 / 21 / 11 / 12 / 1

Earnings Surprises

Recent Analyst Actions

Jun 4, 2026Leerink Partners
Nanobiotix S.A (NBTX) PT Raised to $46 at Leerink
Target:$46.00
+30.7%from $35.20
May 1, 2026UBS
Nanobiotix price target raised to $30 from $3.50 at UBS
Target:$30.00
-13.3%from $34.62
Nov 25, 2025Leerink Partners
Nanobiotix S.A (NBTX) PT Raised to $26 at Leerink Partners
Target:$26.00
+18.2%from $22.00
Sep 18, 2025Leerink Partners
Nanobiotix price target raised to $14 from $9 at Leerink
Target:$14.00
+13.7%from $12.31
Aug 27, 2024Guggenheim
Nanobiotix initiated with a Buy at Guggenheim
Target:$12.00
+133.9%from $5.13
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.